Loading…

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels

Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of disease 2006-06, Vol.22 (3), p.651-656
Main Authors: Pacheco-Quinto, Javier, Rodriguez de Turco, Elena B., DeRosa, Steven, Howard, Altovise, Cruz-Sanchez, Felix, Sambamurti, Kumar, Refolo, Lorenzo, Petanceska, Suzana, Pappolla, Miguel A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313
cites cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313
container_end_page 656
container_issue 3
container_start_page 651
container_title Neurobiology of disease
container_volume 22
creator Pacheco-Quinto, Javier
Rodriguez de Turco, Elena B.
DeRosa, Steven
Howard, Altovise
Cruz-Sanchez, Felix
Sambamurti, Kumar
Refolo, Lorenzo
Petanceska, Suzana
Pappolla, Miguel A.
description Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found. The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.
doi_str_mv 10.1016/j.nbd.2006.01.005
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969996106000076</els_id><doaj_id>oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc</doaj_id><sourcerecordid>68064958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</originalsourceid><addsrcrecordid>eNqFkU2O1DAQhS0EYpqBA7BBXsEqwU5sxxar0QiYkUZiAxI7yz9l2k0SBzs9qDkWB-FMeOgGdrCpkkpfPdWrh9BTSlpKqHi5a2fr244Q0RLaEsLvoQ0lijeK9x_vow1RQjVKCXqGHpWyI4RSroaH6IwKTgWT3QZ9vjoskLdpSu5QVogzTNHhi_HbFuIE-UXBU9oXqNXDiFPAZjqMKfpUYsFlm74WHGeXwRTw2GYT598E_vEdL7Cs0QMe4RbG8hg9CGYs8OTUz9GHN6_fX141N-_eXl9e3DSOMbk2wjgyyKHvxTB0vTTMU2IMsdLIwKzn1WcIKhAaarfAiHHedb13RPXB9bQ_R9dHXZ_MTi85TiYfdDJR_xqk_EmbvEY3gu5kFzjjyjvOWVDSUmppGNgAVnTGuqr1_Ki15PRlD2XVUywOxtHMUB-jhSSCKS7_C1LFhOS8qyA9gi6nUjKEPxdSou9i1TtdY9V3sWpCdbVbd56dxPd2Av9345RjBV4dgfpmuI2QdXERZgc-ZnBrNR7_If8T4ey1dA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19468552</pqid></control><display><type>article</type><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><source>ScienceDirect®</source><creator>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</creator><creatorcontrib>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</creatorcontrib><description>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found. The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</description><identifier>ISSN: 0969-9961</identifier><identifier>EISSN: 1095-953X</identifier><identifier>DOI: 10.1016/j.nbd.2006.01.005</identifier><identifier>PMID: 16516482</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - blood ; Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Alzheimer's disease ; Amyloid beta-Peptides - metabolism ; Amyloidosis ; Amyloidosis - blood ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Animals ; Aβ40 ; Aβ42 ; Blotting, Western ; Brain ; Brain - metabolism ; Brain - pathology ; Brain Chemistry - physiology ; Cell Count ; Cystathionine beta-Synthase - genetics ; Disease Models, Animal ; Female ; Homocysteine - blood ; Hyperhomocysteinemia ; Immunohistochemistry ; Male ; Mice ; Mice, Transgenic ; Mutation ; Neurons - pathology ; Polymerase Chain Reaction ; Sex Factors</subject><ispartof>Neurobiology of disease, 2006-06, Vol.22 (3), p.651-656</ispartof><rights>2006 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</citedby><cites>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0969996106000076$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16516482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pacheco-Quinto, Javier</creatorcontrib><creatorcontrib>Rodriguez de Turco, Elena B.</creatorcontrib><creatorcontrib>DeRosa, Steven</creatorcontrib><creatorcontrib>Howard, Altovise</creatorcontrib><creatorcontrib>Cruz-Sanchez, Felix</creatorcontrib><creatorcontrib>Sambamurti, Kumar</creatorcontrib><creatorcontrib>Refolo, Lorenzo</creatorcontrib><creatorcontrib>Petanceska, Suzana</creatorcontrib><creatorcontrib>Pappolla, Miguel A.</creatorcontrib><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><title>Neurobiology of disease</title><addtitle>Neurobiol Dis</addtitle><description>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found. The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</description><subject>Alzheimer Disease - blood</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloidosis</subject><subject>Amyloidosis - blood</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Animals</subject><subject>Aβ40</subject><subject>Aβ42</subject><subject>Blotting, Western</subject><subject>Brain</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Brain Chemistry - physiology</subject><subject>Cell Count</subject><subject>Cystathionine beta-Synthase - genetics</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Homocysteine - blood</subject><subject>Hyperhomocysteinemia</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mutation</subject><subject>Neurons - pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Sex Factors</subject><issn>0969-9961</issn><issn>1095-953X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkU2O1DAQhS0EYpqBA7BBXsEqwU5sxxar0QiYkUZiAxI7yz9l2k0SBzs9qDkWB-FMeOgGdrCpkkpfPdWrh9BTSlpKqHi5a2fr244Q0RLaEsLvoQ0lijeK9x_vow1RQjVKCXqGHpWyI4RSroaH6IwKTgWT3QZ9vjoskLdpSu5QVogzTNHhi_HbFuIE-UXBU9oXqNXDiFPAZjqMKfpUYsFlm74WHGeXwRTw2GYT598E_vEdL7Cs0QMe4RbG8hg9CGYs8OTUz9GHN6_fX141N-_eXl9e3DSOMbk2wjgyyKHvxTB0vTTMU2IMsdLIwKzn1WcIKhAaarfAiHHedb13RPXB9bQ_R9dHXZ_MTi85TiYfdDJR_xqk_EmbvEY3gu5kFzjjyjvOWVDSUmppGNgAVnTGuqr1_Ki15PRlD2XVUywOxtHMUB-jhSSCKS7_C1LFhOS8qyA9gi6nUjKEPxdSou9i1TtdY9V3sWpCdbVbd56dxPd2Av9345RjBV4dgfpmuI2QdXERZgc-ZnBrNR7_If8T4ey1dA</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Pacheco-Quinto, Javier</creator><creator>Rodriguez de Turco, Elena B.</creator><creator>DeRosa, Steven</creator><creator>Howard, Altovise</creator><creator>Cruz-Sanchez, Felix</creator><creator>Sambamurti, Kumar</creator><creator>Refolo, Lorenzo</creator><creator>Petanceska, Suzana</creator><creator>Pappolla, Miguel A.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20060601</creationdate><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><author>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer Disease - blood</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloidosis</topic><topic>Amyloidosis - blood</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Animals</topic><topic>Aβ40</topic><topic>Aβ42</topic><topic>Blotting, Western</topic><topic>Brain</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Brain Chemistry - physiology</topic><topic>Cell Count</topic><topic>Cystathionine beta-Synthase - genetics</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Homocysteine - blood</topic><topic>Hyperhomocysteinemia</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mutation</topic><topic>Neurons - pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pacheco-Quinto, Javier</creatorcontrib><creatorcontrib>Rodriguez de Turco, Elena B.</creatorcontrib><creatorcontrib>DeRosa, Steven</creatorcontrib><creatorcontrib>Howard, Altovise</creatorcontrib><creatorcontrib>Cruz-Sanchez, Felix</creatorcontrib><creatorcontrib>Sambamurti, Kumar</creatorcontrib><creatorcontrib>Refolo, Lorenzo</creatorcontrib><creatorcontrib>Petanceska, Suzana</creatorcontrib><creatorcontrib>Pappolla, Miguel A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neurobiology of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pacheco-Quinto, Javier</au><au>Rodriguez de Turco, Elena B.</au><au>DeRosa, Steven</au><au>Howard, Altovise</au><au>Cruz-Sanchez, Felix</au><au>Sambamurti, Kumar</au><au>Refolo, Lorenzo</au><au>Petanceska, Suzana</au><au>Pappolla, Miguel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</atitle><jtitle>Neurobiology of disease</jtitle><addtitle>Neurobiol Dis</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>22</volume><issue>3</issue><spage>651</spage><epage>656</epage><pages>651-656</pages><issn>0969-9961</issn><eissn>1095-953X</eissn><abstract>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found. The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16516482</pmid><doi>10.1016/j.nbd.2006.01.005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0969-9961
ispartof Neurobiology of disease, 2006-06, Vol.22 (3), p.651-656
issn 0969-9961
1095-953X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc
source ScienceDirect®
subjects Alzheimer Disease - blood
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer's disease
Amyloid beta-Peptides - metabolism
Amyloidosis
Amyloidosis - blood
Amyloidosis - metabolism
Amyloidosis - pathology
Animals
Aβ40
Aβ42
Blotting, Western
Brain
Brain - metabolism
Brain - pathology
Brain Chemistry - physiology
Cell Count
Cystathionine beta-Synthase - genetics
Disease Models, Animal
Female
Homocysteine - blood
Hyperhomocysteinemia
Immunohistochemistry
Male
Mice
Mice, Transgenic
Mutation
Neurons - pathology
Polymerase Chain Reaction
Sex Factors
title Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A10%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperhomocysteinemic%20Alzheimer's%20mouse%20model%20of%20amyloidosis%20shows%20increased%20brain%20amyloid%20%CE%B2%20peptide%20levels&rft.jtitle=Neurobiology%20of%20disease&rft.au=Pacheco-Quinto,%20Javier&rft.date=2006-06-01&rft.volume=22&rft.issue=3&rft.spage=651&rft.epage=656&rft.pages=651-656&rft.issn=0969-9961&rft.eissn=1095-953X&rft_id=info:doi/10.1016/j.nbd.2006.01.005&rft_dat=%3Cproquest_doaj_%3E68064958%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19468552&rft_id=info:pmid/16516482&rfr_iscdi=true